New York, USA, July 12, 2023 (GLOBE NEWSWIRE) -- Local Anesthesia Drugs Global Market to Proliferate at a CAGR of ~4% by 2028 | DelveInsight
The growing number of surgical procedures performed as a result of the global incidence of chronic diseases is driving up demand for local anesthesia medications. Furthermore, the introduction of new and effective drugs such as articaine, levobupivacaine, and ropivacaine, advancements in drug delivery technologies, the expanded use of local anesthetics in postoperative pain, and the increasing number of drug launches and approvals, among other factors, are all contributing to the overall growth of the local anesthesia drugs market.
DelveInsight’s Local Anesthesia Drugs Market Insights report provides the current and forecast market analysis, individual leading local anesthesia drugs companies’ market shares, challenges, local anesthesia drugs market drivers, barriers, trends, and key market local anesthesia drugs companies in the market.
Key Takeaways from the Local Anesthesia Drugs Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global local anesthesia drugs market during the forecast period.
- Notable local anesthesia drugs companies such as Fresenius Kabi USA, Pacira BioSciences, Inc., Pfizer, Septodont Holding, Baxter, Laboratoires Théa SAS, Luye Pharma Group, PAINPASS, GLENMARK PHARMACEUTICALS LTD., Aspen Group, Endo International plc, Hikma Pharmaceuticals PLC, Nichi-Iko Pharmaceutical Co., Heron Therapeutics, Inc., Teva Pharmaceutical Industries Ltd, and several others, are currently operating in the local anesthesia drugs market.
- In March 2021, Luye Pharma Group received approval for clinical trials by the Centre for Drug Evaluation of China’s National Medical Products Administration for its LY09606, the first Ropivacaine multivesicular liposome formulation local anesthetic to be used as a postoperative analgesic.
- In August 2020, B.Braun Melsulgen AG and Royal Philips announced that Onvision needle tip tracking technology for regional anesthesia got the 510(k) clearance from the US FDA.
To read more about the latest highlights related to the local anesthesia drugs market, get a snapshot of the key highlights entailed in the Global Local Anesthesia Drugs Market Report
Local Anesthesia Drugs Overview
Local anesthesia is a medical technique used to numb a specific area of the body, providing pain relief during various medical procedures. Local anesthesia drugs are typically administered by injection near the targeted nerves or tissues. They may be used alone or in combination with other medications, such as epinephrine, which helps to constrict blood vessels in the area, prolonging the duration of anesthesia and reducing bleeding. Local anesthetics are drugs that are administered in such cases to temporarily block the transmission of pain signals from specific nerves to the brain, allowing procedures to be performed without discomfort. There are two main types of local anesthesia drugs: ester-linked local anesthetics and amide-linked local anesthetics. These drugs work by interfering with the function of sodium channels in nerve cells, preventing the conduction of nerve impulses and blocking the sensation of pain.
Local Anesthesia Drugs Market Insights
North America is expected to account for the highest share of the worldwide local anesthesia drugs market in 2023, out of all regions. Factors such as an increase in the number of surgeries, an aging population suffering from chronic conditions, an increase in the use of local anesthetics in postoperative pain, and advancements in anesthesia administration are expected to aid in the growth of the North American local anesthesia drugs market. Furthermore, high disposable income, advanced healthcare infrastructure, and regulatory approval for innovative pharmaceuticals all contributed to this region’s local anesthesia drugs market growth.
To know more about why North America is leading the market growth in the local anesthesia drugs market, get a snapshot of the Local Anesthesia Drugs Market Outlook
Local Anesthesia Drugs Market Dynamics
The local anesthesia drugs market is seeing increased product demand due to a variety of factors, one of which is the increasing number of surgical procedures worldwide. Moreover, the introduction of novel and effective medications such as articaine, levobupivacaine, and ropivacaine is further fueling the expansion of the local anesthesia drugs market. This expansion is augmented by rising healthcare spending in developing countries such as India, China, and Brazil, where the number of surgeries performed has been steadily increasing.
However, drug-related adverse effects, a restrictive regulatory environment, and other factors may limit the growth of the local anesthesia drugs market.
Additionally, during the COVID-19 pandemic, the local anesthesia drugs market was severely disrupted. The sale of local anesthesia drugs collapsed during the early stages of the pandemic due to the installation of severe lockdown measures and disruptions in manufacture and supply. Furthermore, the pandemic’s spread resulted in the cancellation of outpatient consultations as well as the suspension of non-emergency hospitalization and surgical treatments for a variety of conditions including orthopedic, gynecological, urological, cosmetic, cardiovascular, dental, and others.
However, the invention of the COVID-19 vaccine triggered the economic recovery process. Furthermore, the relaxation of lockdown restrictions and the return to normalcy in the economic landscape triggered the process of resumption of regular healthcare services such as outpatient visits for various treatments, therapies, and surgeries for the aforementioned ailments, bringing demand for products back on track in the local anesthesia drugs market.
Get a sneak peek at the local anesthesia drugs market dynamics @ Local Anesthesia Drugs Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2020–2028 |
| Local Anesthesia Drugs Market CAGR | ~4% |
| Local Anesthesia Drugs Market Size by 2028 | USD 3.5 Billion |
| Key Local Anesthesia Drugs Companies | Fresenius Kabi USA, Pacira BioSciences, Inc., Pfizer, Septodont Holding, Baxter, Laboratoires Théa SAS, Luye Pharma Group, PAINPASS, GLENMARK PHARMACEUTICALS LTD., Aspen Group, Endo International plc, Hikma Pharmaceuticals PLC, Nichi-Iko Pharmaceutical Co., Heron Therapeutics, Inc., Teva Pharmaceutical Industries Ltd, among others |
Local Anesthesia Drugs Market Assessment
- Local Anesthesia Drugs Market Segmentation
- Local Anesthesia Drugs Market Segmentation By Drug Type: Bupivacaine, Lidocaine, Benzocaine, Prilocaine, Chloroprocaine, and Others
- Local Anesthesia Drugs Market Segmentation By Mode of Administration: Surface Anesthetic and Injectable
- Local Anesthesia Drugs Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the local anesthesia drugs market are set to emerge as the trendsetter explore @ Local Anesthesia Drugs Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Local Anesthesia Drugs Market |
| 7 | Local Anesthesia Drugs Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Local Anesthesia Drugs Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the local anesthesia drugs market by 2028? Click to get a snapshot of the Local Anesthesia Drugs Market Trends
Related Reports
Anti-Inflammatory Drugs Market
Anti-Inflammatory Drugs Market Insights, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key anti-inflammatory drugs companies including Amgen Inc., Sun Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Pfizer Inc., Medical Device Business Services, Inc., Novartis AG, GSK plc., F. Hoffmann-La Roche Ltd, AbbVie Inc., AstraZeneca, Merck & Co., Inc., Lilly., Bristol-Myers Squibb Company, Biogen, Aurobindo Pharma, Reckitt Benckiser Group PLC., Dr. Reddy’s Laboratories Ltd., Sanofi, Strides Pharma Science Limited, Heron Therapeutics, Inc., among others.
Anti-Fungal Drugs Market Insights, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key anti-fungal drugs companies including Abbott., Bayer AG, GSK plc., Merck & Co., Inc., Cadila Pharmaceuticals., Glenmark, SCYNEXIS, Inc., Astellas Pharma d.o.o., Arcadia Consumer Healthcare, Novartis AG, Pfizer Inc., Leadiant Biosciences, Inc., Sun Pharmaceutical Industries Ltd., Viatris Inc., Sanofi, Gilead Sciences, Inc., Apotex Inc., Aurobindo Pharma USA, Cipla Inc., Dr. Reddy's Laboratories Ltd., among others.
Anti-Infective Drugs Market Insights, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key anti-infective drugs companies including Merck & Co., Inc., Gilead Sciences, Inc., GSK plc., Pfizer Inc., Alembic Pharmaceuticals, Mankind Pharma, Novartis AG, Abbott., Astellas Pharma d.o.o., Bayer AG, Bristol-Myers Squibb Company, Sanofi, Janssen Global Services, LLC, F. Hoffmann-La Roche Ltd, Cipla Inc., Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Xellia Pharmaceuticals, AbbVie Inc., Melinta Therapeutics LLC, PACIFIC INDIA PHARMA LIMITED, among others.
Antipsychotic Drugs Market Insights, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key antipsychotic drugs companies including Eli Lily and Company, Janssen Global Services, LLC, Pfizer Inc., Otsuka Pharmaceutical Co., Ltd., Alkermes, Inc., Dr. Reddy’s Laboratories Ltd., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., Alvogen., Hikma Pharmaceuticals PLC, Viatris Inc., Bayer AG, Bristol-Myers Squibb Company, Cardinal Health Inc., Sanis Health Inc., H. Lundbeck A/S, Elikem Pharmaceuticals Pvt Ltd, Devlife Corporation Private Limited., GSK plc, among others.
Antiviral Drugs Market Insights, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key antiviral drugs companies including AbbVie Inc., Bristol-Myers Squibb Company, Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Cipla Inc., Lupin., ENTOD INTERNATIONAL, AstraZeneca, Dr. Reddy’s Laboratories Ltd., GSK plc., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi, ViiV Healthcare, Aurobindo Pharma., Sun Pharmaceutical Industries Ltd., Viatris Inc., Boehringer Ingelheim, among others.
Other Trending Reports
Image Guided Surgery Devices Market | Alopecia Market | Chronic Myelogenous Leukemia Market | Neuroblastoma Market | Alzheimer Disease Market | Osteoarthritis Market | Apheresis Market | Scleroderma Market | Hyperhidrosis Market | Opioid Induced Constipation Market | Cervical Intraepithelial Neoplasia Market | Automated External Defibrillators Market | Choroidal Neovascularization Market | Familial Primary Pulmonary Hypertension Market | Meningioma Market | Progressive Multifocal Leukoencephalopathy Market | Chemotherapy Induced Thrombocytopenia Market | Deep Vein Thrombosis Market | Duchenne Muscular Dystrophy Market | Human Papilomavirus Market | Myelofibrosis Market | Postsurgical Pain Market | Stable Angina Market | Trigeminal Neuralgia Market Size | Adult Growth Hormone Deficiency Market | Allergic Rhinitis Market | Angioedema Market | Chronic Inflammtory Demyelinating Polyneuropathy Market | Chronic Lymphocytic Leukemia Cll Market | Colorectal Cancer Market | Encephalitis Market | Rett Syndrome Market | Xerostomia Market | Carpal Tunnel Syndrome Market | Cluster Headache Market | Global Electrophysiology Devices Market | Pharma Licensing Services | Pressure Ulcers Market Size | Blood Gas And Electrolyte Analyzers Market | Chronic Lymphocytic Leukemia Market | Minimal Residual Disease Market | Acute Coronary Syndrome Market | Age-Related Macular Degeneration Market | Ankylosing Spondylitis Market | Contraceptive Devices Market | Eczema Market | Hemodynamic Monitoring Systems Market | Intracranial Pressure Monitoring Devices Market | NCFB Market | Vertigo Market | Nsclc Market | Prefilled Syringes Market | Multiple Myeloma Market | Parkinson's Disease Market | Actinic Keratosis Market | Allergic Conjunctivitis Market | Cervical Cancer Market Size | Concussions Market Size | Neurovascular Devices Market | Ventilator Market
Related Healthcare Services
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
